Foodie Pundit

OMB just cleared FDA paperwork, food system's good 'til 2029

The White House budget office just renewed FDA data collection permits for food additives, infant formula and bottled water through 2029.

By Foodie Pundit Newsroom - Published - Updated - Section: Beverages

Food service activity related to this story. Representative image.

Key points

  • The Office of Management and Budget (OMB) approved several FDA requests to collect information from the public.
  • This is a routine procedural step required by the Paperwork Reduction Act, which ensures the government doesn't create excessive paperwork.
  • The approved collections relate to food safety and regulation, including bottled water, food additives, and infant formula.
  • The approval allows the FDA to continue its mission of protecting public health, and the public benefits from this oversight.
  • The approvals have expiration dates, at which point the FDA must seek renewal, creating a cycle of review and accountability.

The confidence you have in your next meal, your morning coffee, or the infant formula for your kid is built on a mountain of the most tedious, unglamorous government process imaginable. This isn't the stuff of flashy press conferences or angry congressional hearings. This is the deep, structural work of governance, happening in the quiet hum of federal office buildings.

The paper trail documenting that process is where the real story of food safety is found, long before a product is recalled or a new rule is announced. It's the invisible architecture holding up the entire system.

That trail leads straight to the procedural heartbeat of the federal government, a place where paperwork isn't just paperwork, it's power. A recent federal filing shows the Food and Drug Administration, the agency policing a massive portion of the American food supply, just received a series of critical procedural approvals to continue its data-gathering operations. The action created zero immediate headlines and was written in a language so dense it's practically a different dialect of English.

But understanding it is to understand the invisible guardrails that dictate what can and cannot be sold as food in the United States. This isn't a story about a new kale smoothie. It's the story of the system that allows that kale smoothie to exist and, hopefully, not make you sick.

The entire story pivots on a single, official document published in the Federal Register. Think of the Federal Register as the U.S. government's official diary and legally mandated journal for all its formal notices. It is not a press release designed to be understood; it is a formal declaration for the public record, and its density is a feature, not a bug.

On August 17, 2026, a notice from the Food and Drug Administration titled "Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals" appeared. Buried in its bureaucratic prose was the quiet renewal of the FDA's authority to keep tabs on the food industry.

The notice confirms that the Office of Management and Budget, or OMB, has approved a series of FDA requests to collect information from the industries it regulates. This entire process is governed by a law from 1980 called the Paperwork Reduction Act. That law was born from a desire to stop the federal government from burying citizens and businesses under an avalanche of duplicative or pointless forms.

It forces an agency like the FDA to justify every single question it wants to ask the food industry. Before the FDA can compel a company to hand over data, it has to get permission from a more powerful office, one located inside the White House complex. This notice is the receipt for that transaction. OMB Calls The Shots

The ultimate power broker in this story is the Office of Management and Budget. As a part of the Executive Office of the President, OMB is the nerve center for federal spending, management, and regulatory policy. If the federal government were a corporation, OMB would be a combination of the CFO and the COO, holding the power to approve, deny, or change almost any significant action the rest of the government wants to take. OIRA Makes It Official

Within OMB, the real authority for this specific action resides in a lesser-known but immensely powerful group: the Office of Information and Regulatory Affairs, or OIRA. Under the Paperwork Reduction Act, OIRA is the gatekeeper. It is the White House's chief accountant for red tape.

No major federal agency can legally force companies, labs, or individuals to provide information without first getting OIRA's blessing. OIRA's job is to weigh an agency's stated need for information against the estimated time, effort, and money, known as the "burden," that the data collection would impose on the private sector. It has the power to approve, reject, or demand changes to any information collection request from the FDA or any other agency.

The August 17 notice is the public record of OIRA doing its job and giving the FDA the green light.

The direct beneficiary of this bureaucratic win is the Food and Drug Administration. The FDA, which is part of the Department of Health and Human Services, is a colossal federal agency with a mandate covering something like 80 percent of the food sold in the United States, plus drugs, medical devices, cosmetics, and more. Its job is immense and often thankless, a sprawling scientific and regulatory body that most Americans only think about when something goes terribly wrong.

What the FDA gains from this approval is not a budget increase, but something more fundamental: the authority to operate. The OMB approval grants the FDA the legal right to continue its data collection activities, which are the bedrock of its entire mission. The FDA does not, and cannot, inspect every food facility or test every batch of food.

That would be physically and financially impossible. Instead, it operates on a system of science, risk assessment, and, crucially, data provided by the very industries it regulates. Without a constant, legally mandated flow of reliable information from companies, the FDA's ability to evaluate the safety of new products, monitor manufacturing practices, and enforce its own rules would be crippled.

It would be flying blind. The approval documented in the Federal Register notice is what keeps the lights on for these specific, essential oversight functions.

The federal record shows a direct and formal chain of command between the beneficiary and the decider. The Food and Drug Administration, which gets the authority to collect information, is the very agency being regulated in this context. Its request to impose a paperwork burden on an outside industry is subject to the strict review and approval of the Office of Management and Budget.

This relationship is a textbook example of internal executive branch oversight. It's a check and balance built into the system. The FDA, an agency within a cabinet department, must go hat in hand to OMB, an office within the president's own executive suite.

The Paperwork Reduction Act demands this interaction. It sets up the decider (OMB) as the direct regulator of the beneficiary's (FDA) data-gathering ambitions. The August 17 notice is the documentary evidence of this regulated transaction between two arms of the government, proof that the process was followed and approval was granted. The Invisible Bill

The federal record does not show any money changing hands, like a contract award. Instead, the financial implications are calculated in a unique government currency: "burden hours." This is the government's official, highly scrutinized estimate of the total time and effort required for an entire industry to comply with an information collection.

The FDA is required to calculate these figures, justify them, and submit them to OMB for approval. These hours represent real costs to businesses in the form of employee salaries, lab testing fees, and administrative overhead.

The August 17, 2026, Federal Register notice lists the specific approvals granted by OMB, each with its own control number, expiration date, and burden estimate. The key authorizations for the food system include three critical areas. Water, Additives, Formula

For bottled water regulation, the approval carries OMB Control Number 0910-0623. This allows the FDA to require companies to test their water sources and finished products for contaminants and to maintain records of those tests. The FDA's filing, as cited in the notice, estimates the annual reporting burden on the industry to be 44,784 hours.

That's the equivalent of more than 21 full-time employees working year-round, across the entire industry, just on this one piece of compliance. This authorization now runs until August 31, 2029.

For food additive petitions, the approval to process them is assigned OMB Control Number 0910-0016. This is the FDA's front door for any new ingredient, preservative, or coloring that wants to enter the U.S. food supply. It covers the voluminous scientific data companies must submit to prove a new additive is safe for consumption.

The agency estimated the annual recordkeeping burden for this gatekeeping function at 31,988 hours. This approval, according to the notice, expires sooner, on May 31, 2027.

For infant formula notifications, under OMB Control Number 0910-0253, the stakes are arguably the highest. This approval covers "Submissions on New Infant Formulas," a critical control for products fed to the most vulnerable members of the population. Before marketing a new formula, manufacturers must give the FDA detailed data on its nutritional composition and the quality control systems used in its production. The FDA estimated the annual reporting burden for these notifications at 5,460 hours. The OMB approval for this collection now expires on July 31, 2029, as stated in the public notice.

Each of these burden hour estimates represents a quantifiable cost imposed on private industry, as calculated by the FDA and approved by OMB, in exchange for the public benefit of regulatory oversight. How This Happened

The sequence of events documented in the federal record establishes a clear, cyclical timeline for this regulatory action. The process that culminated in the August 17, 2026, notice began months, if not years, earlier.

First, the FDA's internal experts and program managers identified the need to continue these specific information collections to support their regulations. These aren't perpetual approvals; they have expiration dates, forcing the agency to regularly re-justify their existence.

Following that internal determination, the FDA was required by law to publish initial notices in the Federal Register announcing its intent to seek renewal. These notices opened a 60-day public comment period. This is the first chance for industry groups, consumer advocates, academics, and anyone else to submit arguments for or against the renewal. An industry group might argue the burden estimate is too low and the real cost is much higher, while a consumer group might argue the FDA should be collecting even more data.

After the close of that initial comment period, the FDA must review the comments and then publish a second notice, providing an additional 30-day comment period, before finalizing its formal Information Collection Request package to send to OMB. This package includes the final proposed forms, a full justification for the data, a response to public comments, and the final burden hour calculation. Only then does it land on OIRA's desk for the final up-or-down decision. The August notice is the finish line of this long, bureaucratic marathon.

What It Means For Diners Why Your Food Is Safe

This is where the impenetrable language of the Federal Register translates into the reality of your grocery cart. These approvals are not abstract. They are the functional basis for trust in the industrial food system.

The reauthorization for infant formula data collection means that manufacturers continue to be legally required to prove to the FDA that their product is nutritionally sound and safely manufactured before it can be sold. It's a fundamental backstop designed to prevent nutritional deficiencies or contamination in food for newborns and infants.

The approval for the food additive petition process means that the system for evaluating new ingredients, from novel sweeteners to plant-based coloring agents, remains intact. A company can't just decide to dump a new chemical into a soda and see what happens. It must first submit a mountain of scientific evidence to the FDA demonstrating its safety, a process that can take years. This renewal ensures that gatekeeping function continues.

And the green light for bottled water information collection means the FDA can continue to enforce quality standards that, in many cases, are stricter than the EPA's standards for tap water. It ensures companies are testing for E. coli, lead, and other contaminants, giving you a baseline of confidence that the water in the bottle is what it claims to be.

This isn't about one specific new product. It's about the ongoing safety and integrity of thousands of products already on the shelves and all the new ones to come. It's the due diligence that underpins the entire market. This paperwork renewal is the system working as designed, ensuring the baseline level of safety doesn't expire.

The most immediate thing to watch is the expiration date on the food additive petition approval: May 31, 2027. This is the shortest of the three major renewals. That means the FDA will have to begin the renewal process all over again, likely sometime in 2026.

Keep an eye on the Federal Register for the initial 60-day notice. This will be the first signal of the next round. The key questions will be whether the FDA proposes any changes to the information it collects and, critically, whether the "burden hour" estimate changes.

More from the Foodie Pundit Newsroom

Permalink